These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23396871)

  • 1. Immunogenicity and protective efficacy of a dual subunit vaccine against respiratory syncytial virus and influenza virus.
    Park MH; Chang J
    Immune Netw; 2012 Dec; 12(6):261-8. PubMed ID: 23396871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chimeric glycoprotein formulated with a combination adjuvant induces protective immunity against both human respiratory syncytial virus and parainfluenza virus type 3.
    Garg R; Brownlie R; Latimer L; Gerdts V; Potter A; van Drunen Littel-van den Hurk S
    Antiviral Res; 2018 Oct; 158():78-87. PubMed ID: 30071204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual role of respiratory syncytial virus glycoprotein fragment as a mucosal immunogen and chemotactic adjuvant.
    Kim S; Joo DH; Lee JB; Shim BS; Cheon IS; Jang JE; Song HH; Kim KH; Song MK; Chang J
    PLoS One; 2012; 7(2):e32226. PubMed ID: 22384186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
    Lei H; Peng X; Jiao H; Zhao D; Ouyang J
    Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal vaccination of recombinant H5N1 HA1 proteins fused with foldon and Fc induces strong mucosal immune responses with neutralizing activity: Implication for developing novel mucosal influenza vaccines.
    Yu F; Li Y; Guo Y; Wang L; Yang J; Zhao G; Zhou Y; Du L; Jiang S
    Hum Vaccin Immunother; 2015; 11(12):2831-8. PubMed ID: 26260706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An avian influenza A (H7N9) virus vaccine candidate based on the fusion protein of hemagglutinin globular head and Salmonella typhimurium flagellin.
    Song L; Xiong D; Kang X; Yang Y; Wang J; Guo Y; Xu H; Chen S; Peng D; Pan Z; Jiao X
    BMC Biotechnol; 2015 Aug; 15():79. PubMed ID: 26286143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice.
    Bian C; Liu S; Liu N; Zhang G; Xing L; Song Y; Duan Y; Gu H; Zhou Y; Zhang P; Li Z; Zhang K; Wang Z; Zhang S; Wang X; Yang P
    Antiviral Res; 2014 Apr; 104():110-7. PubMed ID: 24509239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonglycosylated G-Protein Vaccine Protects against Homologous and Heterologous Respiratory Syncytial Virus (RSV) Challenge, while Glycosylated G Enhances RSV Lung Pathology and Cytokine Levels.
    Fuentes S; Coyle EM; Golding H; Khurana S
    J Virol; 2015 Aug; 89(16):8193-205. PubMed ID: 26018164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-like particle vaccine by intranasal vaccination elicits protective immunity against respiratory syncytial viral infection in mice.
    Cai M; Wang C; Li Y; Gu H; Sun S; Duan Y; Lai C; Wang K; Yang X; Xing L; Zhang P; Wang Z; Zhang S; Guo X; Liu S; Tong Y; Wang X; Yang P
    Acta Biochim Biophys Sin (Shanghai); 2017 Jan; 49(1):74-82. PubMed ID: 27974288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of safe and effective RSV vaccine by modified CD4 epitope in G protein core fragment (Gcf).
    Cheon IS; Shim BS; Park SM; Choi Y; Jang JE; Jung DI; Kim JO; Chang J; Yun CH; Song MK
    PLoS One; 2014; 9(4):e94269. PubMed ID: 24736750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection.
    Kim S; Jang JE; Yu JR; Chang J
    Vaccine; 2010 May; 28(22):3801-8. PubMed ID: 20362203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cold-adapted influenza vaccine carrying three repeats of a respiratory syncytial virus (RSV) fusion glycoprotein epitope site protects BALB/c mice and cotton rats against RSV infection.
    Xu Y; Sun F; Chuai Z; Wang J; Bai Z; Bian C; Wang X; Zhao Z; Liu Y; Yang P
    Antiviral Res; 2024 Jul; ():105960. PubMed ID: 38986872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.
    Power UF; Plotnicky-Gilquin H; Huss T; Robert A; Trudel M; Ståhl S; Uhlén M; Nguyen TN; Binz H
    Virology; 1997 Apr; 230(2):155-66. PubMed ID: 9143271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral immunization of a non-recombinant Lactococcus lactis surface displaying influenza hemagglutinin 1 (HA1) induces mucosal immunity in mice.
    Jee PF; Tiong V; Shu MH; Khoo JJ; Wong WF; Abdul Rahim R; AbuBakar S; Chang LY
    PLoS One; 2017; 12(11):e0187718. PubMed ID: 29108012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a respiratory syncytial virus vaccine using human hepatitis B core-based virus-like particles to induce mucosal immunity.
    Huang JM; Wang SY; Lai MR; Tseng YK; Chi YH; Huang LM
    Vaccine; 2021 Jun; 39(24):3259-3269. PubMed ID: 33972124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete protection of mice from respiratory syncytial virus infection following mucosal delivery of synthetic peptide vaccines.
    Bastien N; Trudel M; Simard C
    Vaccine; 1999 Feb; 17(7-8):832-6. PubMed ID: 10067688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal vaccine against respiratory syncytial virus A and B subtypes.
    Lee JY; Chang J
    PLoS One; 2017; 12(4):e0175384. PubMed ID: 28384263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats.
    Binjawadagi B; Ma Y; Binjawadagi R; Brakel K; Harder O; Peeples M; Li J; Niewiesk S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The optimized fusion protein HA1-2-FliCΔD2D3 promotes mixed Th1/Th2 immune responses to influenza H7N9 with low induction of systemic proinflammatory cytokines in mice.
    Song L; Xiong D; Kang X; Jiao Y; Zhou X; Wu K; Zhou Y; Jiao X; Pan Z
    Antiviral Res; 2019 Jan; 161():10-19. PubMed ID: 30389471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.